Robert J. Mulroy

2013

In 2013, Robert J. Mulroy earned a total compensation of $2M as President and Chief Executive Officer at Merrimack Pharmaceuticals, a 49% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$187,778
Option Awards$1,325,730
Salary$512,720
Other$12,186
Total$2,038,414

Mulroy received $1.3M in option awards, accounting for 65% of the total pay in 2013.

Mulroy also received $187.8K in non-equity incentive plan, $512.7K in salary and $12.2K in other compensation.

Rankings

In 2013, Robert J. Mulroy's compensation ranked 3,843rd out of 12,286 executives tracked by ExecPay. In other words, Mulroy earned more than 68.7% of executives.

ClassificationRankingPercentile
All
3,843
out of 12,286
69th
Division
Manufacturing
1,302
out of 4,612
72nd
Major group
Chemicals And Allied Products
351
out of 1,462
76th
Industry group
Drugs
245
out of 1,156
79th
Industry
Pharmaceutical Preparations
200
out of 890
78th
Source: SEC filing on March 27, 2015.

Mulroy's colleagues

We found four more compensation records of executives who worked with Robert J. Mulroy at Merrimack Pharmaceuticals in 2013.

2013

Ulrik Nielsen

Merrimack Pharmaceuticals

Chief Scientific Officer

2013

William Sullivan

Merrimack Pharmaceuticals

Chief Financial Officer

2013

William McClements

Merrimack Pharmaceuticals

Head of Corporate Operations

2013

Edward Stewart

Merrimack Pharmaceuticals

Senior Vice President and President, Merrimack Healthcare Solutions

In-depth

You may also like